This is the list of Schedule I drugs as defined by the United States Controlled Substances Act. The following findings are required for drugs to be placed in this schedule:
- The drug or other substance has a high potential for abuse.
- The drug or other substance has no currently accepted medical use in treatment in the United States.
- There is a lack of accepted safety for use of the drug or other substance under medical supervision.
Except as specifically authorized, it is illegal for any person:
- to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance; or
- to create, distribute, dispense, or possess with intent to distribute or dispense, a counterfeit substance.
Additional substances are added to the list by the Secretary of Health and Human Services pursuant to 21 CFR 1308.49.
The complete list of Schedule I drugs follows. The Administrative Controlled Substances Code Number for each drug is included.
Opioids
| ACSCN | Drug |
|---|---|
| 9815 | Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) |
| 9601 | Acetylmethadol |
| 9602 | Allylprodine |
| 9603 | Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) |
| 9604 | Alphameprodine |
| 9605 | Alphamethadol |
| 9814 | Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) |
| 9832 | Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide) |
| 9606 | Benzethidine |
| 9607 | Betacetylmethadol |
| 9830 | Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4- piperidinyl]-N-phenylpropanamide) |
| 9831 | Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2- phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) |
| 9608 | Betameprodine |
| 9609 | Betamethadol |
| 9611 | Betaprodine |
| 9612 | Clonitazene |
| 9613 | Dextromoramide |
| 9615 | Diampromide |
| 9616 | Diethylthiambutene |
| 9168 | Difenoxin |
| 9617 | Dimenoxadol |
| 9618 | Dimepheptanol |
| 9619 | Dimethylthiambutene |
| 9621 | Dioxaphetyl butyrate |
| 9622 | Dipipanone |
| 9623 | Ethylmethylthiambutene |
| 9624 | Etonitazene |
| 9625 | Etoxeridine |
| 9626 | Furethidine |
| 9627 | Hydroxypethidine |
| 9628 | Ketobemidone |
| 9629 | Levomoramide |
| 9631 | Levophenacylmorphan |
| 9813 | 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) |
| 9833 | 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) |
| 9632 | Morpheridine |
| 9661 | MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) |
| 9633 | Noracymethadol |
| 9634 | Norlevorphanol |
| 9635 | Normethadone |
| 9636 | Norpipanone |
| 9812 | Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide |
| 9663 | PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine |
| 9637 | Phenadoxone |
| 9638 | Phenampromide |
| 9647 | Phenomorphan |
| 9641 | Phenoperidine |
| 9642 | Piritramide |
| 9643 | Proheptazine |
| 9644 | Properidine |
| 9649 | Propiram |
| 9645 | Racemoramide |
| 9835 | Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide |
| 9750 | Tilidine |
| 9646 | Trimeperidine |
| 9821 | Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) |
| 9547 | 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]N-methylbenzamide) (U-47700) |
| 9821 | Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) |
| 9834 | N-(1-Phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (furanyl fentanyl) |
| 9811 | Acryl fentanyl ((N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide); Acryloylfentanyl) |
| 9816 | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (Ortho-fluorofentanyl or 2-fluorofentanyl) |
| 9822 | Butyryl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) |
| 9824 | 4-Fluoroisobutyryl fentanyl ((N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) or Para-fluoroisobutyryl fentanyl) |
| 9825 | 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (Methoxyacetyl fentanyl) |
| 9836 | Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide) |
| 9843 | N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (Tetrahydrofuranyl fentanyl) |
| 9845 | (1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (cyclopropyl fentanyl) |
| 9840 | N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl) |
| 9823 | N-(4-fluorophenyl)N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl fentanyl) |
| 9837 | N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-methoxybutyryl fentanyl) |
| 9826 | N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (para-chloroisobutyryl fentanyl) |
| 9827 | N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl) |
| 9847 | N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl fentanyl) |
| 9838 | N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil) |
| 9850 | Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers |
| 9551 | AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) |
| 9560 | MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) |
Opium derivatives
Heroin powder
| ACSCN | Drug |
|---|---|
| 9319 | Acetorphine |
| 9051 | Acetyldihydrocodeine |
| 9052 | Benzylmorphine |
| 9070 | Codeine methylbromide |
| 9053 | Codeine-N-Oxide |
| 9054 | Cyprenorphine |
| 9055 | Desomorphine |
| 9145 | Dihydromorphine |
| 9335 | Drotebanol |
| 9056 | Etorphine (except hydrochloride salt) |
| 9200 | Diacetylmorphine (originally sold in the US under the brand name "Heroin") |
| 9301 | Hydromorphinol |
| 9302 | Methyldesorphine |
| 9304 | Methyldihydromorphine |
| 9305 | Morphine methylbromide |
| 9306 | Morphine methylsulfonate |
| 9307 | Morphine-N-Oxide |
| 9308 | Myrophine |
| 9309 | Nicocodeine |
| 9312 | Nicomorphine |
| 9313 | Normorphine |
| 9314 | Pholcodine |
| 9315 | Thebacon |
Hallucinogenic or psychedelic substances
| ACSCN | Drug |
|---|---|
| 7249 | Alpha-Ethyltryptamine (αET) |
| 7391 | 4-bromo-2,5-dimethoxy-amphetamine (DOB) |
| 7392 | 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) |
| 7396 | 2,5-dimethoxyamphetamine (DOA) |
| 7399 | 2,5-Dimethoxy-4-ethylamphetamine (DOE) |
| 7348 | 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts and salts of isomers |
| 7411 | 4-methoxyamphetamine (PMA) |
| 7401 | 5-methoxy-3,4-methylenedioxyamphetamine (MMDA) |
| 7395 | 4-methyl-2,5-dimethoxyamphetamine (DOM; STP) |
| 7400 | 3,4-methylenedioxyamphetamine (MDA, Sassafrass) |
| 7405 | 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy, Molly) |
| 7404 | 3,4-methylenedioxy-N-ethylamphetamine (MDEA; MDE) |
| 7402 | N-hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy MDA) |
| 7390 | 3,4,5-trimethoxyamphetamine (TMA) |
| 7431 | 5-methoxy-N,N-dimethyltryptamine (5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT) |
| 7432 | Alpha-methyltryptamine (αMT) |
| 7433 | Bufotenine |
| 7434 | Diethyltryptamine (DET) |
| 7435 | Dimethyltryptamine (DMT) |
| 7439 | 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers |
| 7260 | Ibogaine |
| 7315 | Lysergic acid diethylamide (LSD) |
| 7360 | Marijuana, including cannabis resin |
| 7350 | Marijuana extracts; cannabinoids |
| 7381 | Mescaline |
| 7374 | Parahexyl |
| 7415 | Peyote |
| 7482 | N-ethyl-3-piperidyl benzilate |
| 7484 | N-methyl-3-piperidyl benzilate |
| 7437 | Psilocybin |
| 7438 | Psilocin |
| 7370 | Tetrahydrocannabinol (THC) |
| 7455 | Ethylamine analog of phencyclidine (Eticyclidine; PCE) |
| 7458 | Pyrrolidine analog of phencyclidine (PCPy) |
| 7470 | Thiophene analog of phencyclidine (TCP) |
| 7473 | 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (TCPy) |
| 1248 | 4-methylmethcathinone (Mephedrone) |
| 7535 | 3,4-methylenedioxypyrovalerone (MDPV) |
| 7509 | 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) |
| 7508 | 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) |
| 7519 | 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) |
| 7518 | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) |
| 7385 | 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) |
| 7532 | 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) |
| 7517 | 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) |
| 7521 | 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) |
| 7524 | 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) |
| 7540 | 3,4-Methylenedioxy-N-methylcathinone (methylone) |
| 7538 | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5) |
| 7537 | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) |
| 7536 | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) |
Depressants
gamma-Hydroxybutyrate powder
| ACSCN | Drug |
|---|---|
| 2010 | gamma-Hydroxybutyric acid (GHB; sodium oxybate; sodium oxybutyrate) except formulations in an FDA-approved drug product are Schedule III |
| 2572 | Mecloqualone |
| 2565 | Methaqualone |
Stimulants
Products containing BZP.
| ACSCN | Drug |
|---|---|
| 1585 | Aminorex (aminoxaphen; 2-amino-5-phenyl-2- oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) |
| 7493 | N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine), its optical isomers, salts and salts of isomers |
| 1235 | Cathinone |
| 1503 | Fenethylline |
| 1237 | Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers |
| 1590 | (±)-cis-4-methylaminorex |
| 1475 | N-ethylamphetamine |
| 1480 | N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) |
| 7543 | N-Ethylpentylone (ephylone, N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone)) |
| 7246 | N-Ethylhexedrone |
| 7544 | alpha-Pyrrolidinohexanophenone (α-PHP) |
| 7245 | 4-Methyl-alpha-ethylaminopentiophenone (4-MEAP) |
| 7446 | 4'-Methyl-alpha-pyrrolidinohexiophenone (MPHP) |
| 7548 | alpha-Pyrrolidinoheptaphenone (PV8) |
| 7443 | 4-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α-PVP) |
| 1233 | 3-Fluoro-N-methylcathinone (3-FMC; 1-(3-fluorophenyl)-2-(methylamino)propan-1-one) |
| 1238 | 4-Fluoro-N-methylcathinone (4-FMC, flephedrone, 1-(4-fluorophenyl)-2-(methylamino)propan-1-one) |
| 1246 | Pentedrone (α-methylaminovalerophenone, 2-(methylamino)-1-phenylpentan-1-one) |
| 1249 | 4-Methyl-N-ethylcathinone (4-MEC, 2-(ethylamino)-1-(4-methylphenyl)propan-1-one) |
| 1258 | Naphyrone (naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one) |
| 7498 | 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP, MePPP, 4-methyl-α-pyrrolidinopropiophenone,1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one) |
| 7541 | Butylone (bk-MBDB, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one) |
| 7542 | Pentylone (bk-MBDP, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one) |
| 7545 | alpha-pyrrolidinopentiophenone (α-PVP, α-pyrrolidinovalerophenone, 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one) |
| 7546 | alpha-pyrrolidinobutiophenone (α-PBP, 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one) |
Cannabimimetic agents
| ACSCN | Drug |
|---|---|
| 7297 | 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) |
| 7298 | 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) |
| 7118 | 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) |
| 7173 | 1-butyl-3-(1-naphthoyl)indole (JWH-073) |
| 7019 | 1-hexyl-3-(1-naphthoyl)indole (JWH-019) |
| 7200 | 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) |
| 6250 | 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) |
| 7081 | 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081) |
| 7122 | 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) |
| 7398 | 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) |
| 7201 | 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) |
| 7694 | 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) |
| 7104 | 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4) |
| 7008 | 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole 7008 (SR-18 and RCS-8) |
| 7203 | 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) |
| 7144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole) |
| 7011 | [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (5-fluoro-UR-144, 5-F-UR-144, XLR-11, 1-(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole) |
| 7048 | N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (APINACA, AKB-48) |
| 7222 | Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (QUPIC, PB-22) |
| 7225 | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22) |
| 7012 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) |
| 7035 | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA) |
| 7031 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) |
| 7023 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) |
| 7024 | [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) |
| 7034 | 2-(1-(5-Fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-ADB, 5F-MDMB-PINACA) |
| 7033 | Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F-AMB) |
| 7049 | N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-APINACA, 5F-AKB48) |
| 7010 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA) |
| 7042 | Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-CHMICA, MMB-CHMINACA) |
| 7020 | Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-FUBINACA) |
| 7032 | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA) |
| 7036 | ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-EDMB-PINACA) |
| 7041 | methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) |
| 7047 | N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)) |
| 7083 | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (5F-CUMYL-PINACA; SGT-25) |
| 7014 | (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (FUB-144) |
| 7021 | Methyl 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate (FUB–AMB, MMB– FUBINACA, AMB–FUBINACA) |
| 7025 | 5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) |
| 7044 | MMB-CHMICA (AMB-CHMICA, methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) |
| 7085 | 5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3-carboxamide) |
| 7089 | 4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78) |
| 7221 | NM-2201 (CBL2201, Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) |
See also
- List of Schedule II drugs (US)
- List of Schedule III drugs (US)
- List of Schedule IV drugs (US)
- List of Schedule V drugs (US)
- Controlled Substances Act
External links
|